A

Arke Estudios Clinicos S.A. de C.V. | Veracruz, Mexico

Research site
(Unclaimed)
Location
Alacio Perez 928, Offices 101 to 104 Ignacio Zaragoza, Veracruz, Veracruz, Mexico

Site insights

Top conditions

Top treatments

Dulaglutide
LY2189265
Tirzepatide
LY3009104
Ixekizumab
Baricitinib
LY3298176

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 5 total trials

A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis (BREEZE-AD-PEDS)

The reason for this study is to see if the study drug called baricitinib works and is safe in children and teenage participants with atopic dermatiti...

Active, not recruiting
Atopic Dermatitis
Drug: Topical corticosteroid
Drug: Baricitinib

This is a study of tirzepatide in participants with overweight and obesity. The main purpose is to learn more about how tirzepatide affects body weig...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Tirzepatide

This is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis. It will last up to 33 months.

Active, not recruiting
Atopic Dermatitis
Biological: Lebrikizumab

Trial sponsors

Lilly logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems